Literature DB >> 27314915

Study of the involvement of allogeneic MSCs in bone formation using the model of transgenic mice.

Daria Kuznetsova1,2, Natalia Prodanets1, Svetlana Rodimova2, Evgeny Antonov3, Aleksandra Meleshina1, Peter Timashev4, Elena Zagaynova1.   

Abstract

Mesenchymal stem cells (MSCs) are thought to be the most attractive type of cells for bone repair. However, much still remains unknown about MSCs and needs to be clarified before this treatment can be widely applied in the clinical practice. The purpose of this study was to establish the involvement of allogeneic MSCs in the bone formation in vivo, using a model of transgenic mice and genetically labeled cells. Polylactide scaffolds with hydroxyapatite obtained by surface selective laser sintering were used. The scaffolds were sterilized and individually seeded with MSCs from the bone marrow of 5-week-old GFP(+) transgenic C57/Bl6 or GFP(-)C57/Bl6 mice. 4-mm-diameter critical-size defects were created on the calvarial bone of mice using a dental bur. Immediately after the generation of the cranial bone defects, the scaffolds with or without seeded cells were implanted into the injury sites. The cranial bones were harvested at either 6 or 12 weeks after the implantation. GFP(+) transgenic mice having scaffolds with unlabeled MSCs were used for the observation of the host cell migration into the scaffold. GFP(-) mice having scaffolds with GFP(+)MSCs were used to assess the functioning of the seeded MSCs. The obtained data demonstrated that allogeneic MSCs were found on the scaffolds 6 and 12 weeks post-implantation. By week 12, a newly formed bone tissue from the seeded cells was observed, without an osteogenic pre-differentiation. The host cells did not appear, and the control scaffolds without seeded cells remained empty. Besides, a possibility of vessel formation from seeded MSCs was shown, without a preliminary cell cultivation under controlled conditions.

Entities:  

Keywords:  GFP; Mesenchymal stem cells; bone formation; fluorescence imaging; transgenic mice

Mesh:

Year:  2016        PMID: 27314915      PMCID: PMC5479449          DOI: 10.1080/19336918.2016.1202386

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  50 in total

1.  Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate.

Authors:  C M Digirolamo; D Stokes; D Colter; D G Phinney; R Class; D J Prockop
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

Review 2.  Bone graft materials. An overview of the basic science.

Authors:  T W Bauer; G F Muschler
Journal:  Clin Orthop Relat Res       Date:  2000-02       Impact factor: 4.176

3.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

4.  Repair of large bone defects with the use of autologous bone marrow stromal cells.

Authors:  R Quarto; M Mastrogiacomo; R Cancedda; S M Kutepov; V Mukhachev; A Lavroukov; E Kon; M Marcacci
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

5.  Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering.

Authors:  A Wenger; A Stahl; H Weber; G Finkenzeller; H G Augustin; G B Stark; U Kneser
Journal:  Tissue Eng       Date:  2004 Sep-Oct

6.  Effects of plastic-adherent dermal multipotent cells on peripheral blood leukocytes and CFU-GM in rats.

Authors:  S Chunmeng; C Tianmin
Journal:  Transplant Proc       Date:  2004-06       Impact factor: 1.066

7.  In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold.

Authors:  Michael Shin; Hiroshi Yoshimoto; Joseph P Vacanti
Journal:  Tissue Eng       Date:  2004 Jan-Feb

8.  Mesenchymal stem cells can be differentiated into endothelial cells in vitro.

Authors:  Joachim Oswald; Sabine Boxberger; Birgitte Jørgensen; Silvia Feldmann; Gerhard Ehninger; Martin Bornhäuser; Carsten Werner
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model.

Authors:  Vassilios I Sikavitsas; Juliette van den Dolder; Gregory N Bancroft; John A Jansen; Antonios G Mikos
Journal:  J Biomed Mater Res A       Date:  2003-12-01       Impact factor: 4.396

10.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model.

Authors:  A Muraglia; R Cancedda; R Quarto
Journal:  J Cell Sci       Date:  2000-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.